Table 3.
Eleven-Year World Age-Standardized Incident Trend Analysis
Cancer Type | Male (APC, 95% CI) | Female (APC, 95% CI) |
---|---|---|
Breast | 2.85 (1.84,3.87)* | |
Prostate | 9.20 (7.03,11.41)* | |
Lung | 2.07 (0.44,3.73)* | 6.84 (3.51,10.27)* |
Colorectal | 4.71 (2.97,6.47)* | 6.94 (4.78,9.14)* |
Bladder | 2.37 (−1.63,6.53) | 2.09 (−2.27,6.64) |
Stomach | 2.61 (−0.47,5.78) | −0.09 (−3.86,3.82) |
Non-Hodgkin's lymphoma | 0.55 (−2.11,3.28) | 2.80 (−0.27,5.96) |
Thyroid | 6.55 (1.50,11.85)* | 10.17 (7.36,13.06)* |
Liver | 4.38 (1.30,8.82)* | 8.27 (1.49,15.5)*† |
Uterus | 1.17 (−1.09,3.48) | |
Leukemia | 3.39 (0.55,6.31)* | 1.21 (−2.03,4.56) |
Brain | 0.61 (−3.32,4.70) | 1.70 (−2.46,6.05) |
Pancreas | 2.80 (−1.10,6.85)† | 3.94 (−0.63,8.71)† |
Kidney | −1.07 (−4.70,2.69) | −1.27 (−6.17,3.89) |
Gallbladder | −1.11 (−6.93,5.07)† | −1.84 (−6.94,3.55)† |
Ovary | 1.03 (−2.53,4.71) | |
Melanoma of the skin | 8.31 (3.15,13.73)* | 3.62 (−0.72,8.15) |
Multiple myeloma | 4.85 (−0.18,10.13)† | 11.94 (6.24,17.96)* |
Hodgkin's lymphoma | 4.08 (−1.30,9.74) | −1.13 (−6.28,4.31) |
Cervix | −0.21 (−4.09,3.82) | |
Testis | 4.52 (0.19,9.04)* | |
Connective, soft tissue | 6.33 (0.17,12.87)* | 2.36 (−3.52,8.58) |
Larynx | 5.43 (0.74,10.34)* | −1.56 (−14.6,13.46)† |
Bone | −5.59 (−12.87,2.30) | −6.99 (−15.63,2.53) |
Oral cavity | 5.13 (−0.44,11.01) | −1.45 (−8.90,6.62) |
All types | 5.94 (5.12, 6.77)* | 5.47 (4.56,6.40)* |
Statistically significant trend over time at the α=0.05 level
Estimate from Collapsed Age Group analysis